Latest News and Press Releases

Publication of Prospectus Following a routine technical update of the Company's Euro Medium Term Note ("EMTN") programme established in 2007, the following prospectus has been approved by the UK...

AstraZeneca today announced that it has completed the divestment of the global rights to Imdur, outside the US, to China Medical System Holdings Ltd and its associated company, Tibet Rhodiola...

ASTRAZENECA COMPLETES ACQUISITION OF TAKEDA'S RESPIRATORY BUSINESS AstraZeneca today announced that it has completed the acquisition of the core respiratory business of Takeda Pharmaceutical Company...

ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2016 Results of Annual General Meeting held on 29 April 2016 AstraZeneca PLC announced the results of the voting at its Annual General Meeting today.  As...

POSITIVE CHMP OPINION FOR CAZ AVI IN THE EU FOR SERIOUS BACTERIAL INFECTIONS AstraZeneca today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

29 April 2016 Financial Summary +-------------------+-----+----+------+ | | $m | % change | +-------------------+-----+----+------+ | | ...

AstraZeneca First Quarter Results 2016 Tomorrow, Friday, 29 April 2016, AstraZeneca will release first quarter results for 2016 at 07:00 bst. An analyst presentation of the first quarter results...

ASTRAZENECA ENTERS INTO US LICENSING AGREEMENT WITH IRONWOOD PHARMACEUTICALS FOR LESINURAD Agreement includes US rights to Zurampic and lesinurad/allopurinol fixed-dose combination in...

Demonstrated superior improvement in lung function versus mono-components and placebo Only long-acting dual bronchodilator delivered through a pressurised metered -dose inhaler (pMDI) and first...

AstraZeneca AND ELI LILLY AND COMPANY Announce Continuation of Pivotal Clinical Trial for People with Early Alzheimer's Disease Phase II/III trial of AZD3293, an oral potent small molecule BACE...